Odd approach.. Just about every biotech on the ASX is perpetually cum a raise…but whatever
- Forums
- ASX - By Stock
- AGN
- Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-30
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
79.0¢ |
Change
-0.035(4.24%) |
Mkt cap ! $97.72M |
Open | High | Low | Value | Volume |
83.0¢ | 83.0¢ | 79.0¢ | $26.09K | 32.11K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 24611 | 79.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
82.5¢ | 8236 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 24611 | 0.795 |
2 | 2052 | 0.790 |
1 | 14327 | 0.785 |
2 | 12329 | 0.780 |
2 | 7134 | 0.770 |
Price($) | Vol. | No. |
---|---|---|
0.825 | 8236 | 2 |
0.830 | 10752 | 2 |
0.850 | 10000 | 1 |
0.860 | 5000 | 1 |
0.870 | 700 | 1 |
Last trade - 10.23am 30/07/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online